Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05074524 · ClinicalTrials.gov registry record · NA
Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings
A NA study of Opioid Use Disorder and Transcranial Magnetic Stimulation, sponsored by University of Nevada, Las Vegas.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05074524 is a NA study of Opioid Use Disorder and Transcranial Magnetic Stimulation that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 24 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05074524, a NA study of Opioid Use Disorder and Transcranial Magnetic Stimulation, has completed, sponsored by University of Nevada, Las Vegas.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test the effect of repetitive transcranial magnetic stimulation (rTMS) on opioid cravings among adult patients with Opioid Use Disorder.
Conditions Studied
Interventions
- DEVICE Repetitive Transcranial Magnetic Stimulation
- DEVICE Sham Repetitive Transcranial Magnetic Stimulation
Study Locations (1)
Nevada
- University of Nevada, Las Vegas - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-10-06 |
| Est. Completion | 2022-01-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05074524
The ClinicalTrials.gov registry entry for NCT05074524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is University of Nevada, Las Vegas, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Repetitive Transcranial Magnetic Stimulation is the first listed.
NCT05074524 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT05074524 about?
NCT05074524 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings". The purpose of this research study is to test the effect of repetitive transcranial magnetic stimulation (rTMS) on opioid cravings among adult patients with Opioid Use Disorder.
What is the current status of trial NCT05074524?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-10-06. Estimated completion is 2022-01-24.
What conditions does trial NCT05074524 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Transcranial Magnetic Stimulation, Craving, Heroin Abuse.
What interventions are being tested in trial NCT05074524?
The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (DEVICE), Sham Repetitive Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05074524?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05074524 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.